ALAM
MRNA icon

Asahi Life Asset Management’s Moderna MRNA Stock Holding History

Asahi Life Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,330
Closed -$344K – 210
2023
Q3 		$344K Buy
+3,330
New +$371K 0.12% 95
2022
Q3 		– Sell
-2,930
Closed -$419K – 284
2022
Q2 		$419K Buy
+2,930
New +$419K 0.11% 72
2021
Q4 		– Sell
-400
Closed -$154K – 234
2021
Q3 		$154K Sell
400
-960
-71% -$354K 0.02% 218
2021
Q2 		$320K Buy
+1,360
New +$243K 0.04% 138
2020
Q3 		– Sell
-3,360
Closed -$216K – 265
2020
Q2 		$216K Buy
+3,360
New +$184K 0.04% 156

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Asahi Life Asset Management's MRNA Position: Q4 2023 in Review

Asahi Life Asset Management sold out of Moderna (MRNA) in Q4 2023, closing a stake of 3,330 shares — an estimated $344K sold.

Asahi Life Asset Management first reported a position in MRNA in Q2 2020 and held it in 5 quarters. The position peaked at $419K in Q2 2022. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Asahi Life Asset Management reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Asahi Life Asset Management sold 3,330 Moderna shares in Q4 2023, an estimated $344K.
  • Asahi Life Asset Management first reported a position in Moderna in Q2 2020 and held it in 5 quarters.
  • Asahi Life Asset Management's Moderna position peaked at $419K in Q2 2022.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Asahi Life Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.